Surgery for stage 2 seminoma testicular cancer trial
Part of Cancer clinical trials.
This trial is testing whether removing affected lymph nodes with surgery (RPLND) works well alone for seminoma testicular cancer that has spread to nearby nodes but is still relatively small. It is for patients who have not had extensive chemo or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of testicular cancer called pure seminoma, confirmed by biopsy.
- Cancer has spread to lymph nodes in your belly or groin, and the largest spot is 5 cm or smaller.
- You have not had chemotherapy other than a single dose of carboplatin, and you have not had radiation to the belly area.
- Your general health is good, and you do not have a life-threatening or serious mental illness.
- You are willing to have surgery to remove the affected lymph nodes (RPLND).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a robot and a special dye (ICG) to find and remove the first lymph node that might contain cancer cells in men with testicular cancer. It aims to reduce unnecessary lymph node removal while still detecting spread.
This trial tests lowering the intensity of treatment (de-escalation) for Stage II seminoma, a type of testicular cancer. You may receive either a surgery to remove lymph nodes or a single round of chemotherapy (carboplatin), instead of more aggressive standard treatments, to see if it's safe and effective.
This study compares two standard treatments—surgery to remove lymph nodes in the abdomen (RPLND) versus chemotherapy—for men with testicular cancer that has spread to a small area in the abdomen. The goal is to see which approach works better and has fewer side effects.
This trial tests whether a less intensive treatment can be used for testicular seminoma that has spread to nearby lymph nodes but is still small (under 3 cm). It aims to keep the cure rate high while reducing side effects.
This study tests if proton beam therapy, a precise type of radiation, is safe and effective for men with early-stage testicular seminoma that has spread to abdominal lymph nodes. It aims to reduce side effects compared to standard radiation while keeping the cancer controlled.
This study compares giving radiation versus observation (no immediate radiation) for men with advanced seminoma whose PET-CT scan shows a leftover mass after first-line chemotherapy. It aims to see which approach controls the disease better while protecting quality of life.
Hear when a new Seminoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.